Search All News
Columbia cancer researchers are testing a new chemotherapy regimen for patients with an invasive form of bladder cancer who have limited options beyond radical surgery if initial treatment fails.
Dr. McKiernan is a nationally recognized leader in surgical therapies for bladder, kidney, prostate, and testicular cancers.
Two genes together drive the most lethal forms of prostate cancer; could lead to diagnostic test and new treatments.
- February 20, 2014
The American Medical Association has honored P&S student Gregory Joice for his research.
- September 19, 2013
The discovery of progenitor cells in the bladder could lead to new ways to treat chronic bladder pain.
- September 11, 2013
A new genetic test may help determine which men with early prostate cancer can avoid surgery or other invasive treatment.
- July 17, 2013
Mutation linked to congenital urinary tract defects identified.
- November 15, 2012
Link between kidney defects and neurodevelopmental delays in kids
- June 2, 2008